UK buys potential COVID-19 vaccines from J&J and Novavax

The UK government has sealed two more deals to secure COVID-19 vaccines, buying shots in development from US drugmakers Johnson & Johnson and Novavax Inc, the chair of the UK Vaccine Taskforce Katie Bingham told Sky News on Friday.
In a separate statement, Novavax said the UK would buy 60 million doses of its coronavirus vaccine candidate, NVX-CoV2373, for a phase 3 clinical trial in the country.

Subscribe for our daily newsletter
Subscribe for our daily newsletter

By subscribing I accept the terms of use

Read all Tweets >